QODUBWPKNXMVPX-IDISGSTGSA-N
C31H29ClF3N7O3S2 — CID 155380624
Data last refreshed: (MolForge compound catalog, from PubChem)
About QODUBWPKNXMVPX-IDISGSTGSA-N
QODUBWPKNXMVPX-IDISGSTGSA-N (PubChem CID 155380624) has the molecular formula C31H29ClF3N7O3S2 and a molecular weight of 704.20 g/mol. Its IUPAC name is N-[(3R,6S)-3-(2-chloro-4-fluorophenyl)-4-[1-(difluoromethyl)pyrazol-3-yl]-1-(1,3-thiazol-2-yl)-3,5,6,7-tetrahydropyrrolo[1,2-c]pyrimidin-6-yl]-4-hydroxy-4-phenylpiperidine-1-sulfonamide.
Molecular Properties
| Compound Name | QODUBWPKNXMVPX-IDISGSTGSA-N |
|---|---|
| PubChem CID | 155380624 |
| Molecular Formula | C31H29ClF3N7O3S2 |
| Molecular Weight | 704.20 g/mol |
| Exact Mass | 703.14 |
| IUPAC Name | N-[(3R,6S)-3-(2-chloro-4-fluorophenyl)-4-[1-(difluoromethyl)pyrazol-3-yl]-1-(1,3-thiazol-2-yl)-3,5,6,7-tetrahydropyrrolo[1,2-c]pyrimidin-6-yl]-4-hydroxy-4-phenylpiperidine-1-sulfonamide |
| SMILES | O=S(=O)(N[C@H]1CC2=C(c3ccn(C(F)F)n3)[C@H](c3ccc(F)cc3Cl)N=C(c3nccs3)N2C1)N1CCC(O)(c2ccccc2)CC1 |
| InChI | InChI=1S/C31H29ClF3N7O3S2/c32-23-16-20(33)6-7-22(23)27-26(24-8-12-42(38-24)30(34)35)25-17-21(18-41(25)28(37-27)29-36-11-15-46-29)39-47(44,45)40-13-9-31(43,10-14-40)19-4-2-1-3-5-19/h1-8,11-12,15-16,21,27,30,39,43H,9-10,13-14,17-18H2/t21-,27-/m0/s1 |
| InChIKey | QODUBWPKNXMVPX-IDISGSTGSA-N |
| XLogP | 5.33 |
| TPSA | 115.95 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 704.20 |
| LogP ≤ 5 | 5.33 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155380624 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.